Skip to main
TEVA
TEVA logo

Teva Pharmaceutical (TEVA) Earnings Dates & Reports

Teva Pharmaceutical (TEVA) Most Recent Earnings

Report DateJul 30, 2025
Period EndingQ2 2025
Est. EPS$0.61
Actual EPS$0.66
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Teva Pharmaceutical (TEVA) Earnings per Share (EPS) History

Signup for full access
Browse free

Teva Pharmaceutical (TEVA) Latest Earnings

The value each TEVA share was expected to gain vs. the value each share gained.

Teva Pharmaceutical (TEVA) reported its most recent earnings on Jul 30, 2025 for Q2 2025, posting earnings per share (EPS) of $0.66. This exceeded analysts' expectations of $0.61 by 8.20%, marking a Beat.

For comparison, Teva Pharmaceutical reported EPS of $0.61 in the same quarter last year.

The company is expected to announce its next earnings report on 11/05/2025, with analysts projecting an EPS of $0.70.

Teva Pharmaceutical (TEVA) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2025Nov 5, 2025
$0.70Next earnings call Nov. 5, 2025
Q2 2025Jul 30, 2025
$0.61$0.66+8.20%
DeckReportListen
Q1 2025May 7, 2025
$0.46$0.52+13.04%
Q4 2024Jan 29, 2025
$0.70$0.71+1.43%
Q3 2024Nov 6, 2024
$0.66$0.69+4.55%
View all

Teva Pharmaceutical (TEVA) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Teva Pharmaceutical’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Jul 30, 2025
May 7, 2025
Jan 29, 2025
Nov 6, 2024

Teva Pharmaceutical (TEVA) Earnings FAQs

Teva Pharmaceutical (TEVA) last reported earnings on Jul 30, 2025 for Q2 2025, posting an EPS of $0.66, which Beat the estimate of $0.61 by 8.20%.

For Q2 2025, Teva Pharmaceutical (TEVA) reported an EPS of $0.66, exceeding analysts' estimate of $0.61 by 8.20%.

For Q2 2025, Teva Pharmaceutical (TEVA) Beat expectations with an actual EPS of $0.66 vs. an estimated EPS of $0.61.

Following the last earnings report on Jul 30, 2025, Teva Pharmaceutical (TEVA)'s stock price moved — from — to —.

The next Teva Pharmaceutical (TEVA) earnings call is scheduled for Nov. 5, 2025, where executives will discuss financial results and outlook.

Teva Pharmaceutical (TEVA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.